New study tracks Wegovy's safety in pregnancy
NCT ID NCT05872022
First seen Jan 18, 2026 · Last updated May 14, 2026 · Updated 23 times
Summary
This study observes pregnant women who took Wegovy for weight management and compares their health and their babies' health to pregnant women with similar conditions who did not take Wegovy. Researchers will follow infants for one year after birth to check for birth defects or other health issues. The goal is to better understand the safety of using Wegovy during pregnancy.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PREGNANCY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Novo Nordisk Investigational Site
Princeton, New Jersey, 08540, United States
-
Novo Nordisk Investigational Site
Madrid, Spain
-
Novo Nordisk Investigational Site
London, United Kingdom
Conditions
Explore the condition pages connected to this study.